05: The Future of Psychedelics in Healthcare

For over a century, we’ve been in the midst of a revolution in longevity – one that is unprecedented in human history. More than a quarter century has been added to the average lifespan since the 1900s. How should individuals and society make the most of this time? How can we ret ...  Show more

The world today is oversaturated with trends, tips, and treatments for how to live long and be healthy while doing it. But it can be hard to know who to listen to – and what actually works. In this episode, we talk to Dr. Eric Topol, renowned cardiologist and author of the book S ...  Show more

This episode I discuss medical research on psychedelic compounds with Dr. Matthew Johnson, Ph.D., Professor of Psychiatry and Behavioral Sciences at Johns Hopkins School of Medicine. We discuss the biology and medical clinical-trial uses of psilocybin, MDMA, ayahuasca, DMT, and L ...  Show more

When psychedelics were first studied more than 50 years ago, researchers noticed that they were useful in helping people explore a greater sense of self. Now, after a half-century hiatus, scientists are studying psychedelics like MDMA, psilocybin, and ketamine as treatment for de ...  Show more

Bad trips, anti-drug PSAs, and the crackdown under the Controlled Substances Act of 1970 helped stigmatize psychedelics in the U.S. But now, there’s renewed clinical inquiry into whether these drugs can ease emotional trauma. To understand the future of psychedelics, Audie calls ...  Show more

When psychedelics were first studied more than 50 years ago, researchers noticed that they were useful in helping people explore a greater sense of self. Now, after a half-century hiatus, scientists are studying psychedelics like MDMA, psilocybin, and ketamine as treatment for de ...  Show more